Globeflex Capital L P Repligen Corp Transaction History

Globeflex Capital L P

  • $1.15 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $575,740 - $958,364
-2,956 Reduced 99.73%
8 $2,000
Q2 2021

Aug 12, 2021
BUY
$165.87 - $220.95 $1,326 - $1,767
8 Added 0.27%
2,964 $592,000
Q3 2020

Nov 13, 2020
SELL
$122.51 - $158.27 $19,846 - $25,639
-162 Reduced 5.2%
2,956 $436,000
Q2 2020

Aug 12, 2020
BUY
$94.33 - $140.48 $294,120 - $438,016
3,118 New
3,118 $385,000

Others Institutions Holding RGEN

# of Institutions
481
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.82B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email